ESTRAMUSTINE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where ESTRAMUSTINE was used for Neoplasm malignant.
Most Reported Side Effects for ESTRAMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 17 | 6.3% | 3 | 7 |
| Interstitial lung disease | 16 | 6.0% | 10 | 8 |
| Cardiac failure | 15 | 5.6% | 3 | 5 |
| Death | 14 | 5.2% | 14 | 1 |
| Prostatic specific antigen increased | 14 | 5.2% | 9 | 5 |
| Pleural effusion | 10 | 3.7% | 3 | 6 |
| Disease progression | 9 | 3.4% | 5 | 2 |
| Product use issue | 9 | 3.4% | 0 | 0 |
| Anaemia | 8 | 3.0% | 5 | 2 |
| Angioedema | 8 | 3.0% | 0 | 5 |
| Constipation | 8 | 3.0% | 1 | 5 |
| Osteonecrosis of jaw | 8 | 3.0% | 3 | 4 |
| Thrombocytopenia | 8 | 3.0% | 0 | 2 |
| Neutropenia | 7 | 2.6% | 1 | 1 |
| Platelet count decreased | 7 | 2.6% | 0 | 6 |
Other Indications for ESTRAMUSTINE
Prostate cancer (105)
Prostate cancer metastatic (29)
Product used for unknown indication (23)
Hormone-refractory prostate cancer (22)
Breast cancer metastatic (10)
Metastases to bone (6)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)